Abbott Labs says AbbVie places $14.7B in debt
Abbott Laboratories Inc. said Tuesday its branded drug business priced a $14.7 billion private placement of debt. Full story
Abbott Laboratories Inc. said Tuesday its branded drug business priced a $14.7 billion private placement of debt. Full story
Standard & Poor's Ratings Services lowered Abbott Laboratories Inc.'s credit rating Friday as the company prepares to split in two. Full story
Among the earnings stories for Wednesday, Oct. 17, from The Associated Press: Full story
THE JUMP: Shares of Abbott Laboratories Inc. rose Monday after the company said an experimental five-drug regimen cured 99 percent of patients in a 12-week mid-stage clinical trial. Full story
WASHINGTON (Reuters) - A federal judge on Tuesday sentenced Abbott Laboratories Inc to pay $700 million in fines and other costs for illegal marketing of its drug Depakote, in connection with a previously announced settlement, the U.S. Justice Department said. Full story
In a special Salute to the Troops episode of Mad Money, Jim Cramer introduces his father, Ken Cramer, a World War II veteran, and gives investors five reasons they should protect their portfolios with shares of Abbott Labs.
